You just read:

Regen BioPharma, Inc. Addresses Potential Impact of Recent Bristol Myers Squibb $2.3 Billion Acquisition of IFM Therapeutics

News provided by

Regen BioPharma, Inc.

Aug 09, 2017, 07:00 ET